Celularity regains Nasdaq compliance; reporting deficiency remains
Celularity said it regained Nasdaq minimum bid-price and market-value compliance, while a reporting deficiency remains unresolved.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.